Please use selectors to filter reports
May 24, 2024
Unlisted Managed Investment
Neuberger Berman Global High Yield Fund Update
IIR has provided an update report for Neuberger Berman Global High Yield Fund, formerly NB Global Corporate Income Trust....
Request professional access
May 21, 2024
Equity Research Coverage
U.S. Equities
Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Update
We have completed an update report for Acurx following the release of the March quarterly report on 14 May 2024 and the business update provided on 15 May 2024....
Request professional access
May 10, 2024
Listed Managed Investment
Gryphon Capital Income Trust (ASX: GCI) Review
Gryphon Capital Income Trust (ASX: GCI) is a listed investment trust (LIT) designed to provide investors with regular monthly income through an actively managed portfolio of Residential Mortgage Backed Securities (RMBS) and Asset Backed Securities (A...
Request professional access
May 9, 2024
Newsletters
Newsletters & Thematics
Movers & Shakers – Pharma & Biotech
In this edition of the Movers & Shakers for Pharma & Biotech we take a look at four companies whose share prices rallied during the month....
Request professional access
May 7, 2024
Listed Managed Investment
Newsletters
Newsletters & Thematics
LMI Monthly Update
In this edition of the LMI Monthly Update we take a look at the key news items in April as well as provide key data points as at 31 March 2024. ...
Request professional access
May 6, 2024
Company Profile Reporting
Updated Coverage of Revolver Resources (ASX: RRR)
Revolver Resources Ltd (ASX: RRR) is actively and effectively exploring two highly prospective projects in North Queensland - the 874 km2 Dianne Project, over and around the historically-operated Dianne Copper Mine in the Paleozoic Hodgkinson Basin, ...
Request professional access
April 15, 2024
Listed Managed Investment
Qualitas Real Estate Income Fund (ASX: QRI) Review
IIR has completed a review of Qualitas Real Estate Income Fund (ASX: QRI)....
Request professional access
April 8, 2024
Newsletters
Newsletters & Thematics
Movers & Shakers: Pharma & Biotech – 8 April 2024
The Pharma and Biotech market was relatively buoyant in March with 49% of share prices in the coverage universe increasing for the month. There was some significant news flow which resulted in a strong uplift in share prices for some companies........
Request professional access
April 4, 2024
Listed Managed Investment
Newsletters
Newsletters & Thematics
LMI Monthly Update – 3 April 2024
This edition of the monthly update looks at the key newsflow and observations from March 2024 as well as the key data points as at 29 February 2024. ...
Request professional access